Prednisolone
- Generic Name
- Prednisolone
- Brand Names
- Millipred Dp 6 Day
- Drug Type
- Small Molecule
- Chemical Formula
- C21H28O5
- CAS Number
- 50-24-8
- Unique Ingredient Identifier
- 9PHQ9Y1OLM
- Background
Prednisolone is a glucocorticoid similar to cortisol used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.
Prednisolone was granted FDA approval on 21 June 1955.
- Indication
Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.
- Associated Conditions
- Acute Gouty Arthritis, Acute Leukemia, Allergic Bronchopulmonary Aspergillosis, Allergic Conjunctivitis (AC), Allergic Contact Dermatitis, Allergic Skin Reaction, Allergic corneal marginal ulcers, Alveolitis, Extrinsic Allergic, Ankylosing Spondylitis (AS), Aspiration Pneumonia, Aspiration Pneumonitis, Atopic Dermatitis, Bell's Palsy, Berylliosis, Bullous dermatitis herpetiformis, Burns, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Corneal injuries, Corneal ulceration, Crohn's Disease (CD), Cyclitis, Dermatomyositis (DM), Dermatosis of the Ear Canal, Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Erythroblastopenia, Exacerbation of COPD, Exacerbation of asthma, Eye inflammation caused by Cataract Surgery, Eye inflammation caused by Infection, Fissure;Anal, Herpes Zoster Keratitis, Hot Water Burns (Scalds), Hypercalcemia of Malignancy, Idiopathic Pulmonary Fibrosis (IPF), Immune Thrombocytopenia (ITP), Inflamed External Hemorrhoid, Inflamed Hemorrhoids, Internal, Inflammatory Reaction caused by susceptible Bacterial Infections, Iridocyclitis, Iritis, Itching caused by susceptible Bacterial Infections, Keratitis, Loeffler's syndrome, Lymphoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Multiple sclerosis exacerbation, Mycosis Fungoides (MF), Ocular Inflammation, Ophthalmia, Sympathetic, Optic Neuritis, Otic Eczema, Pemphigus, Perennial Allergic Rhinitis (PAR), Pericarditis, Pneumocystis Jirovecii Pneumonia, Polymyalgia Rheumatica (PMR), Posterior Uveitis, Posttraumatic Osteoarthritis, Proctitis, Proteinuria, Pruritus, Pruritus Ani, Psoriatic Arthritis, Pulmonary Tuberculosis (TB), Pure Red Cell Aplasia, Rash, Relapsing Polychondritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Seasonal Allergic Rhinitis, Secondary Adrenal Insufficiency, Secondary thrombocytopenia, Serum Sickness, Severe Asthma, Sjogren's Syndrome (SS), Stevens-Johnson Syndrome, Superficial punctate keratitis, Synovitis, Systemic Lupus Erythematosus, Transplanted Organ Rejection, Trichinosis, Tuberculosis (TB), Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Vasculitis, Acquired immune hemolytic anemia, Acute Bursitis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Anal eczema, Bacterial skin infections, Exfoliative erythroderma, Idiopathic Bronchiolitis obliterans with organizing pneumonia, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Primary adrenocoritical insufficiency, Severe Psoriasis, Severe Seborrhoeic dermatitis, Severe alcoholic liver disease, Steroid-responsive inflammation of the eye, Subacute Bursitis, Susceptible Bacterial Infections, Symptomatic Sarcoidosis, Varicella-zoster virus acute retinal necrosis
- Associated Therapies
- -
CIRcadian Rhythms and CortisoL. Effects on Substrate Metabolism and Clock Gene Expression and Functioning
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 10
- Registration Number
- NCT06035081
- Locations
- 🇩🇰
Department of Endocrinology and Internal Medicine, Aarhus, State, Denmark
The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 20
- Registration Number
- NCT05990985
- Locations
- 🇨🇳
The First Bethune Hospital of Jilin University, Changchun, Jilin, China
Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2023-12-13
- Target Recruit Count
- 62
- Registration Number
- NCT05984381
- Locations
- 🇮🇳
AIIMS Bhubaneswar, Bhubaneswar, Odisha, India
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05961202
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Odense University Hospital
- Target Recruit Count
- 195
- Registration Number
- NCT05947669
- Locations
- 🇬🇧
The Royal Marsden Hospital, London, United Kingdom
🇩🇰Department of Oncology, Aalborg University Hospital, Aalborg, Denmark
🇩🇰Department of Oncology Odense University Hospital, Odense, Denmark
Applying Shear Wave Elastography for Adjunct Steroid on Tuberculous Lymphadenitis
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05861440
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
EFFECTIVENESS OF SINGLE DOSE ORAL DEXAMETHASONE VERSUS MULTIDOSE PREDNISOLONE FOR TREATMENT OF ACUTE EXACERBATIONS OF ASTHMA AMONG CHILDREN ATTENDING THE EMERGENCY DEPARTMENT OF CHILDREN HOSPITAL, ISLAMABAD
- First Posted Date
- 2023-05-09
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- DR. MOHAMMAD ALI ARIF
- Target Recruit Count
- 192
- Registration Number
- NCT05850143
- Locations
- 🇵🇰
Asim Nawaz Niazi, Islamabad, Pakistan
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- October 6 University
- Target Recruit Count
- 90
- Registration Number
- NCT05821075
- Locations
- 🇪🇬
October 6 university hospital, Giza, Egypt
Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-23
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- Wen Zhang
- Target Recruit Count
- 74
- Registration Number
- NCT05781516
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Bejing, China
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- AudioCure Pharma GmbH
- Target Recruit Count
- 210
- Registration Number
- NCT05776459
- Locations
- 🇷🇸
Clinical Hospital Centre Zvezdara, Belgrade, Serbia
🇩🇪SRH Zentralklinikum Suhl GmbH, Suhl, Germany
🇦🇹Ordensklinikum Linz GmbH Barmherzige Schwestern, Linz, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath